Intraoperative Low-Dose Dexmedetomidine Administration Associated with Reduced Hepatic Ischemia-Reperfusion Injury in Pediatric Deceased Liver Transplantation: A Retrospective Cohort Study
Open Access
- 17 September 2021
- journal article
- research article
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 26, e933354-1-e933354-7
- https://doi.org/10.12659/aot.933354
Abstract
Intraoperative Low-Dose Dexmedetomidine Administration Associated with Reduced Hepatic Ischemia-Reperfusion Injury in Pediatric Deceased Liver Transplantation: A Retrospective Cohort Study - Article abstract #933354Keywords
This publication has 39 references indexed in Scilit:
- Analysis of ischemia/reperfusion injury in time‐zero biopsies predicts liver allograft outcomesLiver Transplantation, 2014
- Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trialBritish Journal of Anaesthesia, 2014
- Effect of dexmedetomidine on lung ischemia-reperfusion injuryMolecular Medicine Reports, 2013
- Ischaemia–reperfusion injury in liver transplantation—from bench to bedsideNature Reviews Gastroenterology & Hepatology, 2012
- ForewordKidney International Supplements, 2012
- Liver-protecting effects of omega-3 fish oil lipid emulsion in liver transplantationWorld Journal of Gastroenterology, 2012
- Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantationLiver Transplantation, 2011
- N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantationNephrology Dialysis Transplantation, 2010
- Prolonged use of dexmedetomidine in an infant with respiratory failure following living donor liver transplantationPediatric Anesthesia, 2006
- The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantationTransplant International, 1998